Re­call re­port: AvKARE some­how mixed its an­ti­de­pres­sant and erec­tile dys­func­tion meds; Tor­rent pulls throm­bo­cy­to­sis drug

Any num­ber of is­sues can lead to an FDA re­call, but here’s one you don’t see every day: A third-par­ty man­u­fac­tur­er for Ten­nessee-based AvKARE ap­par­ent­ly mixed an an­ti­de­pres­sant and erec­tile dys­func­tion med in­to the same pack­ag­ing, cre­at­ing a po­tent — if ac­ci­den­tal — mix for pa­tients.

The FDA on Wednes­day an­nounced AvKARE launched a vol­un­tary re­call of one lot each of gener­ic tra­zodone, the an­ti­de­pres­sant, and silde­nafil, an erec­tile dys­func­tion med­ica­tion, af­ter dis­cov­er­ing the two med­ica­tions had been mixed to­geth­er.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.